Health

The UK’s opioid crisis: why the stats don’t add up

By Will Barker, The Week Uk

Copyright theweek

The UK’s opioid crisis: why the stats don’t add up

SUBSCRIBE & SAVE

Less than $3 per week

View Profile

The Explainer

Talking Points

The Week Recommends

Newsletters

From the Magazine

The Week Junior

Food & Drink

Personal Finance

All Categories

Newsletter sign up

the explainer

The UK’s opioid crisis: why the stats don’t add up

A new report has revealed that the UK’s total of opioid-related deaths could be much greater than official figures show

Newsletter sign up

The report has profound implications on both government and social understanding of drug issues

(Image credit: Illustration by Stephen Kelly / Shutterstock / Getty Images)

Will Barker, The Week UK

17 September 2025

Between 2011 and 2022 the number of opioid-related deaths in England and Wales was more than 50% higher than figures given by the Office for National Statistics (ONS), according to a new report from King’s College London.

This report has profound implications on both government and social understanding of drug issues, with UK opioid problems reflecting a “serious drug-related deaths crisis”, said the lead author of the report, Dr Caroline Copeland.
It is also “likely” that the ONS data has “underestimated” the number of deaths due to other substances, such as cocaine, which could also have significant long-term consequences.

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

Sign up for The Week’s Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Why has the number of opioid deaths been under-reported?
Though the “total number of drug deaths is accurate”, the count for deaths due to “specific substances” is obscured as the ONS does not have access to post-mortem reports or toxicology results, the report said.

The ONS is solely reliant on the information provided by the coroner on the death certificate. If multiple drugs are present – often termed “polydrug use” – the findings cannot be interpreted.
As expected, the information collected on these deaths is a major driver of policy, and “fewer people might have died if drug policies had been based on accurate statistics”, a former civil servant told the BBC. The government is now working alongside coroners to “improve the reporting of deaths”.
How many people are killed by opioids in the UK?
The UK has “the largest heroin market in Europe” with “around 300,000 users in England alone”, said The Independent.

Sign up for Today’s Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Contact me with news and offers from other Future brandsReceive email from us on behalf of our trusted partners or sponsorsBy submitting your information you agree to the Terms & Conditions and Privacy Policy and are aged 16 or over.
King’s College London research estimates a total of 39,232 deaths in England and Wales in the 11-year range of its report, compared to just over 25,000 in the official report by the ONS, which shows that the number of opioid-related deaths doubled between 2012 and 2023 from 22.9 to 43.8.
In Scotland, there is a different system surrounding inquests. Instead of the ONS, the National Records of Scotland (NRS) collates official information. There are no coroners, with the Procurator Fiscal conducting Fatal Accident Inquiries.
The NRS does “receive more detailed pathology reports, but differences in how deaths are reported across the UK make it difficult to compare”, said the BBC.
Why is it getting worse?
There was never a “more dangerous time to take drugs”, said the National Crime Agency last year, though if current trends continue, the situation is set to become worse still.
Nitazenes – types of New Synthetic Opioids (NSOs) – seem to be the leading cause, as one of the “fastest-growing groups of new psychoactive substances” in the world, said The Independent.
Many opioid users are not aware they might also be consuming nitazenes, which are judged to be “50 times more potent than heroin”.
NSOs’ potency means they are used in smaller doses, so they can be transported in smaller quantities while still serving the same number of customers, making them much more attractive to sellers.
They still pose a potentially lethal threat to users who know they’re taking NSOs: the drugs’ “therapeutic window” – the dosage range where individuals experience the desired effects without “unacceptable” side-effects – is “very narrow”, said The Economist.
What can be done?
Governments around the world have been left scratching their heads deciding how to tackle this rapidly evolving, and potentially fatal, problem.
Because nitazenes are concocted in labs, they can be altered easily. Producers can make an “entirely new product of similar potency”, which is “not subject to the ban”, said The Economist.
In the UK, in May 2024, 15 synthetic opioids, “including 14 nitazenes”, were controlled as Class A drugs under the Misuse of Drugs Act 1971, said the Home Office.
In July 2025, China, one of the largest producers of NSOs, introduced “generic scheduling of all nitazene-related substances”, to back up the internationally recognised Convention on Psychotropic Substances (1971), said Public Health Scotland.
Ultimately, if governing bodies do not take further action, continue to keep up to date with new variations, and collate accurate statistics, tackling the opioid crisis could suffer “underfunding” and surging risks in “accidental overdose” for users, said Dr Copeland.

Swipe to scroll horizontally

Row 0 – Cell 0
Row 0 – Cell 1
Row 0 – Cell 2

Row 1 – Cell 0
Row 1 – Cell 1
Row 1 – Cell 2

Row 2 – Cell 0
Row 2 – Cell 1
Row 2 – Cell 2

Will Barker, The Week UK

The 9 restaurants to eat at this very moment

The Week Recommends
They’re award-winning. Isn’t that reason enough?

Gaza genocide: will UN ruling change anything?

Today’s Big Question
Commission of Inquiry’s findings ‘give unprecedented weight’ to genocide claims

How The Summer I Turned Pretty has brought out the worst in its fans

In the Spotlight
Amazon’s love-triangle hit ‘driving some of the most bonkers and unhinged online energy in the history of the internet’

You might also like

Why the FDA wants to restrict kratom-related products

In the Spotlight
The compound is currently sold across the United States

US overdose deaths plunged 27% last year

Drug overdose still ‘remains the leading cause of death for Americans aged 18-44,’ said the CDC

Could medics’ misgivings spell the end of the assisted dying bill?

Today’s Big Question
The Royal College of Psychiatrists has identified ‘serious concerns’ with the landmark bill – and MPs are taking notice

Trump seeks to cut drug prices via executive order

The president’s order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts

FDA approves painkiller said to thwart addiction

Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years

The UK’s first legal drug consumption room

The Explainer
‘Potentially transformative moment in UK drugs policy’ as The Thistle opens in Glasgow

Drugmakers paid pharmacy benefit managers to avoid restricting opioid prescriptions

Under the radar
The middlemen and gatekeepers of insurance coverage have been pocketing money in exchange for working with Big Pharma

ADHD drugs shortage: what’s behind it?

The Explainer
Supply chain issues and ‘tripling’ of prescriptions concerns GPs as problems getting medication become ‘desperate’

View More ▸

Contact Future’s experts

Terms and Conditions

Privacy Policy

Cookie Policy

Advertise With Us

The Week is part of Future US Inc, an international media group and leading digital publisher. Visit our corporate site.

Future US, Inc. Full 7th Floor, 130 West 42nd Street